ArticleHarm reduction journal2025
"I don't let anybody die on my watch": perspectives on the intersection of community overdose response and emergency medical services among people who use drugs in Seattle, WA.
Article in Harm reduction journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Community supervision during Oregon's partial decriminalization Measure 110: Criminal legal system involvement, overdose, and naloxone access.Drug and alcohol dependence reports · 2026Article
- Applying the Consolidated Framework for Implementation Research (CFIR) to understand college health administrator perceptions on adopting and implementing opioid overdose education and naloxone distribution (OEND) programs among universities nationally.Harm reduction journal · 2026Article
- "All it's gonna tell you is if it has fentanyl or not:" Perceptions of fentanyl and drug checking among first responders and people who use drugs.Journal of substance use and addiction treatment · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundThe increasing implementation of harm reduction strategies such as take-home naloxone has placed people who use drugs (PWUD) in the position of overdose responders during overdose events, but the perspectives of PWUD are underrepresented in public health policy and practice concerning overdose response. We conducted this study to examine PWUD's perspectives on first response services for overdose and to learn how PWUD can be supported more effectively when they respond to overdoses.
methodsThe Research with Expert Advisors on Drug Use (READU) team, a community-based research team that includes academically trained researchers and people with lived and living experience conducted 13 semistructured interviews with PWUD in King County. The data were analyzed via thematic analysis. The Consolidated Framework for Implementation Research (CFIR) was used to guide the development of the interview protocol and as a framework for qualitative codebook development.
resultsParticipants were asked to describe their experiences with EMS, including police, during overdose response. Most had reversed an overdose themselves and demonstrated commitment to their role as overdose responders. Participants had mixed feelings about EMS involvement in overdose response, citing concerns about stigma and coercion. Police response was described as negatively impacting peer overdose response, with participants stating that past experiences of arrest and harassment by police during overdose response contributed to their reluctance to call 911 during an overdose.
conclusionThe findings from this study demonstrate the important role of PWUD in overdose response and suggest that improving interactions between EMS and PWUD could positively impact future responses, including increasing PWUD's willingness to call 911 during overdose events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.